Cardlytics, Inc. — Director's Dealing 2022

May 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2022-05-05

Reporting Person: Laube Lynne Marie (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-05	Common Stock	S	17973	$33.60	Disposed	358530	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14565	Indirect
Common Stock	14565	Indirect

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022.

F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.30 to $33.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F3: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.

F4: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.